Skip to main content
Clinical Trials/NL-OMON33222
NL-OMON33222
Withdrawn
Not Applicable

Reduction of antibiotic use in the ICU: Procalcitonin guided versus conventional antibiotic therapy in patients with sepsis in the ICU - Procalcitonin in the IC

Alysis Zorggroep0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Alysis Zorggroep
Enrollment
50
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Alysis Zorggroep

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients admitted to the ICU
  • 2\. Age \>18 years
  • 3\. Antibiotic therapy for sepsis with a suspected or proven focus of infection

Exclusion Criteria

  • 1\. Age \<18 years
  • 2\. Pregnancy
  • 3\. Infection or presumed infection requiring prolonged antibiotic therapy (osteomyelitis, meningitis, endocarditis, septic arthritis, mediastinitis, tuberculosis, Pneumocystis jiroveci pneumonia, Toxoplasmosis, Legionellosis, Listeriosis)
  • 4\. Indication for prolonged systemic prophylactic antibiotic therapy
  • 5\. Severe viral or parasitic infections (hemorrhagic fever, malaria)
  • 6\. Antibiotic therapy started 48 hours before enrollment
  • 7\. Severe immunocompromised patients (AIDS with a CD4 count\<200cells/mm3, severe neutropenia(\<500 neutrophils/mm3\), patients undergoing immunosuppressive therapy after solid organ transplantation)
  • 8\. Patients foregoing lifesustaining treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials